Home » Topics » Disease categories and therapies » Urology

Urology
RSS

PAI-1 inhibitors TM-5275 and TM-5441 show promise to treat diabetic nephropathy

July 4, 2011

Vivus seeks approval in U.S. of avanafil for erectile dysfunction

July 1, 2011

Final data presented from phase I trial of X-Excite versus Viagra

June 27, 2011

FDA approves CorMedix's SPA for phase III CRMD-001 trial

June 23, 2011

Phase I results reported on renin inhibitor VTP-27999

June 20, 2011

Bardoxolone methyl enters pivotal trial in patients with chronic kidney disease and type 2 diabetes

June 17, 2011

Enrollment complete in phase II CRMD-001 trial in contrast-induced acute kidney injury

June 16, 2011

FDA grants orphan drug status to Neo-Urinary Conduit

June 15, 2011

NovaDel Pharma files IND with FDA for sildenafil oral spray

June 7, 2011

Ferring and Kyowa Hakko Kirin conclude copromotion agreement for desmopressin tablets in Japan

June 2, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...